Yiqun G Shellman

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Cell death & disease

Cancers

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, Kylie Michel, Kasey L Couts, Karoline A Lambert, William A Robinson, Martin D McCarter, David A Norris, Richard P Tobin, Yiqun G Shellman
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. Cell death & disease 15 (3) (2024)
Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, Kylie Michel, Kasey L Couts, Karoline A Lambert, William A Robinson, Martin D McCarter, David A Norris, Richard P Tobin, Yiqun G Shellman
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. Cell death & disease 15 (3) (2024)
Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, Kylie Michel, Kasey L Couts, Karoline A Lambert, William A Robinson, Martin D McCarter, David A Norris, Richard P Tobin, Yiqun G Shellman
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. Cell death & disease 15 (3) (2024)
Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, Kylie Michel, Kasey L Couts, Karoline A Lambert, William A Robinson, Martin D McCarter, David A Norris, Richard P Tobin, Yiqun G Shellman
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade. Cell death & disease 15 (3) (2024)
Christopher M Clements, Samantha X Shellman, Melody H Shellman, Yiqun G Shellman
TBM Hunter: Identify and Score Canonical, Extended, and Unconventional Tankyrase-Binding Motifs in Any Protein. International journal of molecular sciences 24 (23) (2023)
Christopher M Clements, Morkos A Henen, Beat Vogeli, Yiqun G Shellman
The Structural Dynamics, Complexity of Interactions, and Functions in Cancer of Multi-SAM Containing Proteins. Cancers 15 (11) (2023)
Chiara R Dart, Nabanita Mukherjee, Carol M Amato, Anabel Goulding, Morgan MacBeth, Robert J Van Gulick, Kasey L Couts, James R Lambert, David A Norris, William A Robinson, Yiqun G Shellman
A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Nabanita Mukherjee, Carol M Amato, Jenette Skees, Kaleb J Todd, Karoline A Lambert, William A Robinson, Robert Van Gulick, Ryan M Weight, Chiara R Dart, Richard P Tobin, Martin D McCarter, Mayumi Fujita, David A Norris, Yiqun G Shellman
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma. Cancers 12 (8) (2020)
Nabanita Mukherjee, Jenette Skees, Kaleb J Todd, Drake A West, Karoline A Lambert, William A Robinson, Carol M Amato, Kasey L Couts, Robert Van Gulick, Morgan MacBeth, Kelsey Nassar, Aik-Choon Tan, Zili Zhai, Mayumi Fujita, Stacey M Bagby, Chiara R Dart, James R Lambert, David A Norris, Yiqun G Shellman
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells. Cell death & disease 11 (6) (2020)
Carol M Amato, Jennifer D Hintzsche, Keith Wells, Allison Applegate, Nicholas T Gorden, Victoria M Vorwald, Richard P Tobin, Kelsey Nassar, Yiqun G Shellman, Jihye Kim, Theresa M Medina, Matthew Rioth, Karl D Lewis, Martin D McCarter, Rene Gonzalez, Aik-Choon Tan, William A Robinson
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy. Cancers 12 (7) (2020)
Nabanita Mukherjee, Andrew Strosnider, Bay Vagher, Karoline A Lambert, Sarah Slaven, William A Robinson, Carol M Amato, Kasey L Couts, Judson G T Bemis, Jacqueline A Turner, David A Norris, Yiqun G Shellman
BH3 mimetics induce apoptosis independent of DRP-1 in melanoma. Cell death & disease 9 (9) (2018)

Yiqun G Shellman.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yiqun G Shellman